Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
2,310,854
-
Share change
-
-228,250
-
Total reported value
-
$404,115,318
-
Price per share
-
$174.82
-
Number of holders
-
119
-
Value change
-
-$39,781,267
-
Number of buys
-
63
-
Number of sells
-
43
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q2 2015
As of 30 Jun 2015,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,310,854 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, Brookstone Capital Management, ARS Wealth Advisors, LLC, LPL Financial LLC, BROWN ADVISORY INC, RAYMOND JAMES & ASSOCIATES, and Braver Wealth Management, LLC.
This page lists
119
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.